Skip to main content
. 2020 Mar 15;201(6):671–680. doi: 10.1164/rccm.201908-1644OC

Table 1.

Baseline Characteristics according to Presence of Early COPD among Individuals under 50 Years of Age with 10 Pack-Years or Greater of Tobacco Consumption in the Copenhagen General Population Study

  No COPD (n = 6,889) Early COPD (n = 1,175)
General characteristics    
 Age, yr 45.0 (42.0–47.6) 45.9 (42.8–48.1)*
 Sex, M, no. (%) 3,181 (46) 490 (42)*
 BMI, kg/m2 25.7 (23.4–28.7) 24.6 (22.5–27.3)*
 FEV1 predicted, % 97 (88–105) 83 (74–92)*
 FVC predicted, % 99 (90–107) 101 (90–111)*
 FEV1/FVC 0.79 (0.76–0.83) 0.68 (0.65–0.70)*
 Current smokers, no. (%) 3,167 (46) 678 (58)*
 Tobacco consumption, pack-years 18.8 (13.5–26.0) 22.5 (15.0–30.0)*
 Age at smoking initiation, yr 15.0 (14.0–17.0) 15.0 (14.0–17.0)*
 Poor socioeconomic status, no. (%) 1,123 (16) 233 (20)*
Clinical characteristics, no. (%)    
 FEV1 < LLN of predicted 638 (9) 492 (42)*
 FEV1 < 80% of predicted 596 (9) 471 (40)*
 FEV1 < 50% of predicted 2 (<1) 32 (3)*
 FEV1/FVC < 0.70 2 (<1) 879 (75)*
 Chronic mucus hypersecretion 722 (10) 234 (20)*
 Dyspnea 2,307 (33) 538 (46)*
 mMRC ≥2 454 (7) 124 (11)*
 Night-time dyspnea 293 (4) 108 (9)*
 Wheezing 1,867 (27) 543 (46)*
 Cough 1,339 (19) 378 (32)*
 First-degree relative with asthma 1,347 (20) 336 (29)*
 Childhood asthma/allergy 1,259 (18) 280 (24)*
 Asthma 354 (5) 180 (15)*
 Treatment with airway medication 245 (4) 155 (13)*
 Physically inactive 763 (11) 162 (14)*
 Bronchitis/pneumonia episodes in the last 10 yr 1,868 (27) 414 (35)*
 General practitioner visits in the last 12 mo 5,280 (77) 947 (81)*
 Alpha-1 antitrypsin < 1 g/L 648 (9) 107 (9)
 Blood eosinophils ≥ 300 cells/μl 1,304 (19) 254 (22)*

Definition of abbreviations: BMI = body mass index; COPD = chronic obstructive pulmonary disease; LLN = lower limit of normal; mMRC = modified Medical Research Council dyspnea scale.

Data presented as median (25th–75th percentiles) or number (%). Early COPD was defined as FEV1/FVC less than LLN.

*

P < 0.05 for comparison with individuals without COPD, obtained from Wilcoxon’s rank-sum, Pearson’s χ2 tests, or Fischer’s exact test.